Viewing nowLosacard Tablets 50mg (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Seohung Co., Ltd.

MFDS item code 201906117 · Approved 2019.08.28 · Insurance code 679601170
Treatment of hypertension and kidney disease in patients with type 2 diabetes and hypertension
This medicine is used to treat hypertension and is particularly effective in patients with hypertension who also have nephropathy due to type 2 diabetes. It helps to stabilize blood pressure and prevent deterioration of kidney function, thus used for improvement of kidney problems caused by hypertension and diabetes.
This medicine may be taken regardless of meals, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same total daily dose may be given orally in 2 divided doses, or the dose may be increased to a maximum of 100 mg once daily if necessary. 3) If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive (e.g., a low-dose diuretic). An additive effect has been observed when administered with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special populations 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients 75 years of age or younger. For patients over 75 years of age, an initial dose of 25 mg once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients receiving dialysis: An initial dose of 25 mg once daily is recommended. 3) Patients with reduced intravascular effective circulating volume An initial dose of 25 mg once daily is recommended for patients who may have reduced intravascular effective circulating volume (e.g., patients receiving diuretics) (see Precautions for Use). 4) Patients with hepatic impairment Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
2) Children and adolescents 6 years of age and older (1) Patients weighing 20 kg or more but less than 50 kg who can swallow tablets: The recommended dose is 25 mg once daily. The dose may be increased to a maximum of 50 mg once daily according to the patient's blood pressure response. (2) Patients weighing 50 kg or more: The usual recommended dose is 50 mg once daily. The dose may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. (3) Not recommended for children younger than 6 years, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.
This drug can cause serious harm to the fetus when taken during pregnancy, especially during the second and third trimesters, so it should be discontinued immediately once pregnancy is confirmed. Women who may become pregnant or are pregnant should not take this drug, as it may cause issues with fetal lung development or skeletal formation. This drug should not be used in patients with severe liver dysfunction or hereditary angioedema. Additionally, patients with specific genetic issues such as galactose intolerance should avoid this medication. Caution should be exercised when prescribing this drug to the elderly, patients with reduced kidney function, or those with hyperkalemia, and blood pressure and kidney function should be monitored regularly. Since this drug has an effect of lowering blood pressure, if blood pressure drops too low, symptoms such as dizziness or loss of consciousness may occur, so caution is necessary. There is a risk of increased serum potassium levels, so it is advisable not to take this drug with potassium supplements or medications containing potassium. During the administration of this drug, if any unusual symptoms occur such as liver function abnormalities, changes in kidney function, or allergic reactions, immediate consultation with medical personnel is necessary. In particular, if symptoms of angioedema (swelling of the face, lips, throat, etc.) occur, the drug should be discontinued immediately, and emergency treatment should be sought. This drug is not recommended for use in nursing women, so it is preferable to discontinue breastfeeding while taking this medication. This drug should not be administered to children, especially those under 6 years of age or those with severely reduced kidney function. While taking this drug, caution should be exercised during driving or operating machinery due to possible dizziness. In case of overdose, hypotension and abnormal heart rates may occur, and if symptoms appear, immediate medical treatment should be obtained.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly sealed container to prevent exposure to air and moisture, at a safe temperature between 1 degree to 30 degrees Celsius. Proper storage will help maintain the drug's efficacy and prevent deterioration.
White oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Seohung Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.